Since aspirin is an HMGB1 inhibitor, and we have shown that TLR3 activation induces TLR2 expression, it is possible that the observed effect of the HMGB1 inhibitor on tumor sphere survival is linked to TLR2 and its inability to be activated with its ligand. The gene discussed is TLR3; the disease is neoplasm.